The integration of emotional, physiologic,and communication responses to medical oncology surveillance appointments during breast cancer survivorship

Cancer Nursing

Volumn 40, Issue 2, 2017, Pages 124-134

  Clayton, Margaret F ^a   Dingley, Catherine ^b   Donaldson, Gary ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

Anxiety; Breast cancer survivorship; Cancer communication; Emotional distress; Immunity; Quality of life; Uncertainty

Indexed keywords

BIOLOGICAL MARKER; CD19 ANTIGEN; CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANXIETY; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVOR; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONFUSION (UNCERTAINTY); CYTOTOXIC T LYMPHOCYTE; EMOTION; FEMALE; HUMAN; INNATE IMMUNITY; INTERPERSONAL COMMUNICATION; LYMPHOCYTE COUNT; NATURAL KILLER CELL; PATIENT ATTITUDE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SELF REPORT; BREAST NEOPLASMS; DOCTOR PATIENT RELATION; ETIOLOGY; MENTAL STRESS; MIDDLE AGED; ONCOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVOR; TUMOR RECURRENCE; UNCERTAINTY; VERY ELDERLY; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; BREAST NEOPLASMS; COMMUNICATION; FEMALE; HUMANS; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHYSICIAN-PATIENT RELATIONS; RISK ASSESSMENT; STRESS, PSYCHOLOGICAL; SURVIVORS; UNCERTAINTY; WATCHFUL WAITING;

EID: 84963984716     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0000000000000375     Document Type: Article

References (53)

1. American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2014-2015. Atlanta, GA: American Cancer Society, Inc.; 2014.
2. Institute of Medicine and National Research Council. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academy of Sciences; 2006.
3. Mishel M, Clayton M. Uncertainty in illness theories. In: Smith MJ, Liehr P, eds. Middle Range Theories in Advanced Practice Nursing. 2nd ed. New York: Springer; 2008.
4. Brashers DE, Neidig JL, Haas SM, Dobbs LK, Cardillo L, Russell JA. Communication in the management of uncertainty: the case of persons living with HIV or AIDS. Commun Monogr. 2000;67(1):63-84.
5. Deboeck PR, Bergeman CS. The Reservoir Model: a differential equation model of psychological regulation. Psychol Methods. 2013;18(2):237-256.
6. Clayton M, Dudley W, Musters A. Communication with breast cancer survivors. Health Commun. 2008;23(3):207-221.
7. Clayton M, Mishel M, Belyea M. Testing a model of symptoms, com-munication, uncertainty, and well-being, in older breast cancer survivors. Res Nurs Health. 2006;29(1):18-39.
8. Gaudine A, Sturge-Jacobs M, Kennedy M. The experience of waiting and life during breast cancer follow-up. Res Theory Nurs Pract. 2003;17(2): 153-168.
9. Gil KM, Mishel M, Belyea M, et al. Triggers of uncertainty about re currence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum. 2004;31(3): 633-639.
10. Curtis R, Ron E, Hankey B, Hoover R. New Malignancies Following Breast Cancer. Bethesda, MD: National Cancer Institute; 2006. NIH Publication 05-5302.
11. Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence-a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95-105.
12. Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16-24.
13. Savard J, Ivers H. The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res. 2013;74(4):354-360.
14. Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (9/=5 years) cancer survivors-a systematic review of quantitative studies. Psychooncology. 2013;22(1):1-11.
15. Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300-322.
16. Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psychooncology. 2013;22(9):2059-2063.
17. Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505-511.
18. Ghazali N, Cadwallader E, Lowe D, Humphris G, Ozakinci G, Rogers SN. Fear of recurrence among head and neck cancer survivors: longitudinal trends. Psychooncology. 2013;22(4):807-813.
19. Gold SM, Zakowski SG, Valdimarsdottir HB, Bovbjerg DH. Stronger endocrine responses after brief psychological stress in women at familial risk of breast cancer. Psychoneuroendocrinology. 2003;28(4):584-593.
20. Vitetta L, Anton B, Cortizo F, Sali A. Mind-body medicine: stress and its impact on overall health and longevity. Ann N Y Acad Sci. 2005;1057: 492-505.
21. Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006;79(6):1093-1104.
22. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006;6(3):240-248.
23. Kop WJ. The integration of cardiovascular behavioral medicine and psycho-neuroimmunology: new developments based on converging research fields. Brain Behav Immun. 2003;17(4):233-237.
24. H1 cytokines. 354. Int J Cancer. 2002;100:347-354.
25. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4): 601-630.
26. van der Pompe G, Antoni MH, Visser A, Heijnen CJ. Effect of mild acute stress on immune cell distribution and natural killer cell activity in breast cancer patients. Biol Psychol. 1998;48(1):21-35.
27. Reiche EM, Morimoto HK, Nunes SM. Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry. 2005;17(6):515-527.
28. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5(10):617-625.
29. Clayton M, McCance K. Stress & disease. In: McCance KL, Huether SE, eds. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 7th ed. St Louis, MO: Elsevier; 2014.
30. Antoni MH, Lechner S, Diaz A, et al. Cognitive behavioral stress man-agement effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun. 2009;23(5): 580-591.
31. Thornton LM, Andersen BL, Crespin TR, Carson WE. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun. 2007;21(2):185-194.
32. Porter LS, Mishel M, Neelon V, Belyea M, Pisano E, Soo MS. Cortisol levels and responses to mammography screening in breast cancer survivors: a pilot study. Psychosom Med. 2003;65(5):842-848.
33. de Brabander B, Gerits P. Chronic and acute stress as predictors of relapse in primary breast cancer patients. Patient Educ Couns. 1999;37(3):265-272.
34. Lasagna L. Modernized version of the Hippocratic Oath: written in 1964 by Louis Lasagna, academic dean of the School of Medicine at Tufts University. 1964. http://www.pbs.org/wgbh/nova/doctors/oath-modern.html. Accessed July 22, 2015.
35. Finset A, Graugaard PK, Holgersen K. Salivary cortisol response after a medical interview: the impact of physician communication behaviour, depressed affect and alexithymia. Patient Educ Couns. 2006;60(2):115-124.
36. Mishel MH. Uncertainty in illness. Image J Nurs Scholarsh. 1988;20(4): 225-232.
37. Mishel MH. Reconceptualization of the uncertainty in illness theory. Image J Nurs Scholarsh. 1990;22(4):256-262.
38. Clayton M, Dudley W. Patient-centered communication during oncology follow-up visits for breast cancer survivors: content and temporal structure. Oncol Nurs Forum. 2009;36(2):E68-E79.
39. Palli D, Russo A, Saieva C, et al. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA. 1999; 281(17):1586.
40. Belkora JK, Loth MK, Chen DF, Chen JY, Volz S, Esserman LJ. Mon-itoring the implementation of consultation planning, recording, and summarizing in a breast care center. Patient Educ Couns. 2008;73(3):536-543.
41. Step MM, Rose JH, Albert JM, Cheruvu VK, Siminoff LA. Modeling patient-centered communication: oncologist relational communication and patient communication involvement in breast cancer adjuvant therapy decision-making. Patient Educ Couns. 2009;77(3):369-378.
42. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978;1(5):373-378.
43. McCorkle R, Quint-Benoliel J. Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease. Soc Sci Med. 1983;17(7):431-438.
44. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209-218.
45. Veit CT, Ware JE Jr. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51(5):730-742.
46. Mishel M. Mishel Uncertainty in Illness Scale (MUIS). Glendale, CA: CINAHL Information Systems; 1999.
47. Spielberger C. Manual for the State-Trait Anxiety Inventory STAI (form Y) "Self-Evaluation Questionnaire." Palo Alto, CA: Consulting Psychologists Press; 1983.
48. Martins TB, Pasi BM, Litwin CM, Hill HR. Heterophile antibody inter-ference in a multiplexed fluorescent microsphere immunoassay for quanti-tation of cytokines in human serum. Clin Diagn Lab Immunol. 2004;11(2): 325-329.
49. Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res. 1997;29(3):21-43.
50. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and deci-sional preferences in women with breast cancer. JAMA. 1997;277(18): 1485-1492.
51. Ramfelt E, Langius A, Bjorvell H, Nordstrom G. Treatment decision-making and its relation to the sense of coherence and the meaning of the disease in a group of patients with colorectal cancer. Eur J Cancer Care (Engl). 2000; 9(3):158-165.
52. Breen MS, Beliakova-Bethell N, Mujica-Parodi LR, et al. Acute psychological stress induces short-term variable immune response [published online ahead of print October 22, 2015]. Brain Behav Immun.
53. Heidrich SM, Egan JJ, Hengudomsub P, Randolph SM. Symptoms, symp-tom beliefs, and quality of life of older breast cancer survivors: a comparative study. Oncol Nurs Forum. 2006;33(2):315-322.